ANXA5 and neoplasm: To gain further insight into the potential and limitations of Annexin V-based apoptosis, we evaluated this approach in response to anti-cancer drugs that exert differential effects on the tumor tissue: the chemotherapeutic agent carboplatin and the strong anti-angiogenic drug sunitinib.